Results 21 to 30 of about 721,295 (295)

Impact of acute total occlusion of the culprit artery on outcome in NSTEMI based on the results of a large national registry

BMC Cardiovascular Disorders, 2021
Background The impact of acute total occlusion (TO) of the culprit artery in non-ST-segment elevation myocardial infarction (NSTEMI) is not fully established.
Michał Terlecki, Wiktoria Wojciechowska, Dariusz Dudek, Zbigniew Siudak, Krzysztof Plens, Tomasz J. Guzik, Tomasz Drożdż, Jan Pęksa, Stanisław Bartuś, Wojciech Wojakowski, Marek Grygier, Marek Rajzer   +11 more
doaj   +1 more source

Chronic Kidney Disease and Arterial Stiffness: A Two-Way Path

Frontiers in Medicine, 2021
The kidney-heart relationship has raised interest for the medical population since its vast and complex interaction significantly impacts health. Chronic kidney disease (CKD) generates vascular structure and function changes, with significant hemodynamic
Felipe Inserra, Felipe Inserra, Pedro Forcada, Pedro Forcada, Agustina Castellaro, Carlos Castellaro, Carlos Castellaro   +6 more
doaj   +1 more source

Effect of a reduction in glomerular filtration rate after nephrectomy on arterial stiffness and central hemodynamics: rationale and design of the EARNEST study [PDF]

, 2014
Background: There is strong evidence of an association between chronic kidney disease (CKD) and cardiovascular disease. To date, however, proof that a reduction in glomerular filtration rate (GFR) is a causative factor in cardiovascular disease is ...
Alam, Arena, Bahous, Benetos, Blacher, Blacher, Boudville, Briet, Charles J. Ferro, Charles R. Tomson, Chue, Chue, Daniel Zehnder, DeLoach, Doucende, Edwards, Eknoyan, Faul, Fehrman-Ekholm, Foley, Forbat, Frimodt-Moller, Garg, Go, Groenink, Grothues, Guerin, Hametner, Ian B. Wilkinson, Ibrahim, Jackson, John R. Cockcroft, Jonathan N. Townend, Kasiske, Krohn, Landray, Lang, Laurent, Laurie A. Tomlinson, Levey, Lewington, Luzardo, Maceira, Madero, Mafham, Mark, Martensson, Matsushita, Michels, Moody, Moody, Myerson, Nagueh, National Kidney Foundation, O'Brien, Patrick B. Mark, Richard P. Steeds, Rook, Rothwell, Savage, Schiffrin, Schiller, Segev, Tavakol, Townsend, Vickery, Wang, Wei, Weiss, Wiesmann, Wilkinson, William E. Moody, Yeon, Young   +73 more
core   +2 more sources

Arterial Hypertension and Risk of Mortality in Patients with COVID-19 Infection

Southeastern European Medical Journal, 2022
COVID-19 is currently a major global health concern. Among many unanswered questions related to COVID-19, some of the most debated ones are those concerning arterial hypertension.
Nikolina Bukal, Melanija Kolarić, Ines Golubić, Josipa Josipović, Vedran Premužić, Ana Jelaković, Sandra Karanović, Nikolina Bašić Jukić, Bojan Jelaković   +8 more
doaj   +1 more source

Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation [PDF]

, 1932
Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Arterial hypertension is highly prevalent after renal transplantation and may contribute to the risk of cardiovascular disease.
Morales, José M.
core   +1 more source

Irisin and Cardiometabolic Disorders in Obesity: A Systematic Review

International Journal of Inflammation, 2023
Background. Overweight and obesity are global health issues, impacting a significant portion of young adults. Obesity is a complex condition influenced by genetics and environmental factors, leading to increased susceptibility to cardiovascular diseases (
Jorge da Silva Pinho-Jr, Flávio Andrade Camacho, Carollyne dos Santos Cavararo, Paula Ferreira Baião, Renata Frauches Medeiros, Sérgio Girão Barroso, Andrea Cardoso de Matos   +6 more
doaj   +1 more source

MicroRNA-483 amelioration of experimental pulmonary hypertension. [PDF]

, 2020
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit.
Bai, Liang, Chen, Shanshan, Chou, Chih-Hung, Cui, Xiaopei, Fan, Fenling, Gongol, Brendan, Gu, Mingxia, He, Ming, He, Yangyang, Huang, Hsien-Da, Jing, Zhi-Cheng, Lei, Yuyang, Li, Zhao, Malhotra, Atul, Miao, Yifei, Rabinovitch, Marlene, Shen, Yuan, Shyy, John Y-J, Wang, Xiaojian, Yan, Xiaosong, Zhang, Jiao, Zhang, Jin, Zhang, Yixin   +22 more
core   +1 more source

PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE

Рациональная фармакотерапия в кардиологии, 2015
Aim: to study cerebral blood flow and cholesterol metabolism in menopausal women with arterial hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations in these patients during 6-month antihypertensive and
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova   +3 more
doaj   +1 more source

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential

Frontiers in Cardiovascular Medicine, 2023
Pulmonary arterial hypertension (PAH) is a disease characterized by elevated pulmonary vascular resistance and pulmonary artery pressure. Mortality remains high in severe cases despite significant advances in management and pharmacotherapy.
Jakob Körbelin, Julius Klein, Julius Klein, Christiane Matuszcak, Christiane Matuszcak, Johannes Runge, Johannes Runge, Lars Harbaum, Hans Klose, Jan K. Hennigs, Jan K. Hennigs   +10 more
doaj   +1 more source

Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension

ERJ Open Research, 2023
Background The 2022 ESC/ERS guidelines on pulmonary hypertension recommend noninvasive risk assessments based on three clinical variables during follow-up in patients with pulmonary arterial hypertension (PAH).
Jonna Ostermann, Julian Pott, Jan K. Hennigs, Kevin Roedl, Christoph Sinning, Lars Harbaum, Hans Klose   +6 more
doaj   +1 more source